ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,460, issued on May 13.

"Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections" was invented by Julian Daich (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Attenuate coronavirus species that are able to fully replicate and spread are proposed together with the methods of obtaining thereof. The proposed coronavirus species are intended to treat and prevent viral infections including all those caused by coronavirus species that affect humans as the COVID-19 caused by the SARS-CoV2. Compared with other treatment or vaccine alternatives, the availability of such attenuate coronavirus ...